ADIL
NASDAQ · Pharmaceuticals
Adial Pharmaceuticals Inc
$4.63
-0.17 (-3.54%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Price Target
Analyst Price Target
+279.5% upside
Low Target
$13.09
Average Target
$17.57
High Target
$22.70
Current Price
$4.63
Current
$4.63
$4.63
Target
$17.57
$17.57
$13.09
$17.57 avg
$22.70
Scenario Analysis
Bear Case
$13.09
182.7%
Low target
Base Case
$17.57
+279.5%
Avg target
Bull Case
$22.70
+390.3%
High target
Risk/Reward
2.1x
Favorable
Price in Context
Target vs 52W High
$17.57
-93.7% vs high
Next Earnings Report
Aug 11, 2026
2d
until earnings
EPS Est: $-1.04
Earnings in 2 days. Analyst targets may shift significantly after the report.
Peer Consensus — Pharmaceuticals